SCORSETTI, Marta
 Distribuzione geografica
Continente #
NA - Nord America 20.775
AS - Asia 11.605
EU - Europa 4.213
SA - Sud America 2.370
AF - Africa 576
Continente sconosciuto - Info sul continente non disponibili 369
OC - Oceania 44
AN - Antartide 1
Totale 39.953
Nazione #
US - Stati Uniti d'America 20.364
SG - Singapore 7.301
BR - Brasile 1.935
CN - Cina 1.779
VN - Vietnam 1.205
IT - Italia 1.021
FI - Finlandia 647
DE - Germania 608
IE - Irlanda 540
NG - Nigeria 363
HK - Hong Kong 331
FR - Francia 312
GB - Regno Unito 238
CA - Canada 213
IN - India 188
NL - Olanda 188
SE - Svezia 157
AR - Argentina 154
RU - Federazione Russa 115
BD - Bangladesh 112
TR - Turchia 91
MX - Messico 87
IQ - Iraq 85
EC - Ecuador 69
ID - Indonesia 68
CO - Colombia 62
ZA - Sudafrica 60
PK - Pakistan 54
CL - Cile 52
UA - Ucraina 52
IL - Israele 51
PL - Polonia 49
ES - Italia 48
BE - Belgio 42
AU - Australia 38
SA - Arabia Saudita 37
JP - Giappone 36
VE - Venezuela 35
AT - Austria 32
MA - Marocco 30
UZ - Uzbekistan 30
CZ - Repubblica Ceca 25
JO - Giordania 25
KE - Kenya 24
DZ - Algeria 22
EG - Egitto 22
JM - Giamaica 21
PY - Paraguay 21
MY - Malesia 20
NP - Nepal 20
PE - Perù 20
KZ - Kazakistan 19
LT - Lituania 18
OM - Oman 18
PH - Filippine 18
RO - Romania 18
AE - Emirati Arabi Uniti 17
AZ - Azerbaigian 17
TN - Tunisia 17
UY - Uruguay 15
A2 - ???statistics.table.value.countryCode.A2??? 13
CR - Costa Rica 13
HN - Honduras 12
CH - Svizzera 11
GR - Grecia 11
BG - Bulgaria 9
NO - Norvegia 9
PA - Panama 9
AL - Albania 8
DO - Repubblica Dominicana 8
LB - Libano 8
TT - Trinidad e Tobago 8
GT - Guatemala 7
IR - Iran 7
PS - Palestinian Territory 7
PT - Portogallo 7
SN - Senegal 7
BB - Barbados 6
BH - Bahrain 6
BO - Bolivia 6
CI - Costa d'Avorio 6
GE - Georgia 6
HU - Ungheria 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
BY - Bielorussia 5
DK - Danimarca 5
ET - Etiopia 5
HR - Croazia 5
KG - Kirghizistan 5
KH - Cambogia 5
KR - Corea 5
KW - Kuwait 5
NI - Nicaragua 5
RS - Serbia 5
SI - Slovenia 5
SV - El Salvador 5
BS - Bahamas 4
EE - Estonia 4
EU - Europa 4
Totale 39.528
Città #
Singapore 3.290
Wilmington 2.607
Chandler 2.172
Dallas 1.852
Ashburn 1.182
The Dalles 1.035
San Mateo 1.014
Shanghai 765
San Jose 755
Ann Arbor 720
Helsinki 644
Council Bluffs 613
Dublin 535
Leawood 456
Princeton 448
Lawrence 438
Beijing 407
Boardman 404
Ho Chi Minh City 395
Milan 394
New York 367
Benin City 361
Hanoi 299
Hong Kong 291
Fairfield 261
Woodbridge 252
Paris 241
Falkenstein 239
Santa Clara 237
Los Angeles 186
São Paulo 181
Amsterdam 153
Rome 139
Phoenix 137
Buffalo 113
London 109
Seattle 109
Toronto 92
Norwalk 73
Rio de Janeiro 63
San Diego 60
Da Nang 59
Orem 59
Belo Horizonte 49
Figino 46
Kocaeli 46
Haiphong 45
Miami 45
Naples 42
Brussels 39
Chicago 39
Mexico City 37
Chennai 36
Baghdad 35
Warsaw 34
Brooklyn 32
Porto Alegre 32
Curitiba 31
Montreal 31
Tokyo 31
Philadelphia 30
Brasília 29
Charlotte 29
Dhaka 28
Columbus 27
Hillsboro 27
Munich 27
Frankfurt am Main 26
Guarulhos 25
Tashkent 25
Guayaquil 24
Johannesburg 24
Nuremberg 24
Amman 23
Hải Dương 23
Pune 23
Redwood City 23
San Francisco 23
Redmond 22
Boston 21
Campinas 21
Fortaleza 21
Thái Bình 21
Des Moines 20
Milwaukee 20
Nairobi 20
Salvador 20
Santiago 20
Biên Hòa 19
Denver 19
Manchester 19
Monmouth Junction 19
Oakland 19
Atlanta 18
Can Tho 18
Lahore 18
Quito 18
Vienna 18
Moscow 17
Ninh Bình 17
Totale 25.742
Nome #
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. 762
11C Choline PET Guided Salvage Radiotherapy with Volumetric Modulation Arc Therapy and Hypofractionation for Recurrent Prostate Cancer after HIFU Failure: Preliminary Results of Tolerability and Acute Toxicity 684
"Early Clinical Assessment Of Feasibility And Safety In Flattering Filter Free (FFF) Based Stereotactic Body Radiotherapy (SBRT) Treatments" 157
Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases 152
Hypofractionation with simultaneous boost in breast cancer patients receiving adjuvant chemotherapy: A prospective evaluation of a case series and review of the literature 148
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study 146
Assessment of prognostic factors in patients with metastatic epidural spinal cord compression (MESCC) from solid tumor after surgery plus radiotherapy: a single institution experience 145
A circulating miRNA signature to implement diagnostic imaging analysis in young early-stage breast cancer patients 137
Can advanced new radiation therapy technologies improve outcome of high grade glioma (HGG) patients? Analysis of 3D-conformal radiotherapy (3DCRT) versus volumetric-modulated arc therapy (VMAT) in patients treated with surgery, concomitant and adjuvant chemo-radiotherapy 135
Carbon-11-methionine PET-CT as an imaging biomarker in brain gliomas eligible for surgery 130
Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme 128
High incidence of hypocalcemia and serum creatinine increase in patients with bone metastases treated with zoledronic acid 126
Addition of temozolomide to radiotherapy for treatment of newly diagnosed anaplastic gliomas 125
"Reirradiation: hopes and concerns of the radiation oncologist" Reply 123
A Radiomic Approach to Predict Nodal and Distant Relapse in Patients Treated with Stereotactic Body Radiation Therapy for Early Stage NSCLC 122
Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation. 121
Can HSRS on tumor bed replace WBRT in resected brain metastases? Results of a phase II study 119
Can SBRT improve the prognosis of unresectable pancreatic cancer? Clinical results on 106 patients 118
A broad scope knowledge based model for optimization of VMAT in esophageal cancer: validation and assessment of plan quality among different treatment centers. 117
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma 117
Accuracy evaluation of fusion of CT, MR, and SPECT images using commercially available software packages (SRS PLATO and IFS) 116
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 116
ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study (CROSS): Single Center Experience 116
Role of Surgical Resection in Patients with Single Large Brain Metastases: Feasibility, Morbidity, and Local Control Evaluation. 115
Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach 115
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 115
A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group 114
Survival outcome and prognostic factors after pulmonary metastasectomy in sarcoma patients 114
A LARGE, MULTICENTER, RETROSPECTIVE STUDY ON EFFICACY AND SAFETY OF STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN OLIGOMETASTATIC OVARIAN CANCER (MITO RT1 STUDY) 114
A radiomic approach to predicting nodal relapse and disease-specific survival in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer. 112
SALVAGE RADIOTHERAPY WITH VOLUMETRIC MODULATION ARC THERAPY AND HYPOFRACTIONATION FOR RECURRENT PROSTATE CANCER AFTER HIFU FAILURE 112
Adjuvant volumetric modulated arc therapy compared to 3D conformal radiation therapy for newly diagnosed soft tissue sarcoma of the extremities: outcome and toxicity evaluation 111
Checkpoint inhibitors as treatment for malignant gliomas: "A long way to the top" 108
Diagnostic accuracy of C-11-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma 108
Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis. 107
Adjuvant chemotherapy and hypofractionated VMAT treatment with SIB for early stage breast cancer: A prospective evaluation of acute toxicity and cosmetic results 107
Cranio-spinal irradiation with volumetric modulated arc therapy: A multi-institutional treatment experience 107
Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography 106
A Multi-Institutional Analysis on the Use of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Lymph Node Oligometastases in Prostate Cancer Patients 106
Deep learning-based optimization of field geometry for total marrow irradiation delivered with volumetric modulated arc therapy 105
AI differentiates radionecrosis from true progression in brain metastasis upon stereotactic radiosurgery: analysis of 124 histologically assessed lesions 105
Applying failure mode effects and criticality analysis in radiotherapy: Lessons learned and perspectives of enhancement 105
Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction 105
Adjuvant radiotherapy in endometrial cancer: Volumetric Modulated Intensity Arc Therapy vs 3DRT 105
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study 104
Accuracy evaluation of the optical surface monitoring system on EDGE linear accelerator in a phantom study. 104
Percutaneous Vertebral Augmentation in Metastatic Disease: State of the Art 104
Mesenchymal Tumor Management: Integrating Surgical and Non-Surgical Strategies in Different Clinical Scenarios 102
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 99
Phase II trial of stereotactic body radiation therapy for abdomino-pelvic lymph node oligometastases 98
Value of Surgical Resection in Patients with Newly Diagnosed Grade III Glioma Treated in a Multimodal Approach: Surgery, Chemotherapy and Radiotherapy 98
Developing an adolescent and young adult (AYA) cancer program in an Italian adult high-volume cancer center. 96
The use of radiation therapy for oligoprogressive/oligopersistent oncogene driven non small cell lung cancer: state of the art 96
DCIS treated with breast conservative surgery and radiotherapy: a national multicentre experience 95
Acute Toxicity and Quality of Life in a Post-Prostatectomy Ablative Radiation Therapy (POPART) Multicentric Trial 94
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 94
Hypofractionated stereotactic radiation therapy in skull base meningiomas 94
Role of C-11-choline PET/CT in radiation therapy planning of patients with prostate cancer 94
Early clinical experience with volumetric modulated arc therapy in head and neck cancer patients 93
Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma 92
Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma 92
Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma. 92
Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer 92
Back to (new) normality-A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2 92
Oligoscore: a clinical score to predict overall survival in patients with oligometastatic disease treated with stereotactic body radiotherapy 91
Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study. 91
Deep learning and atlas-based models to streamline the segmentation workflow of total marrow and lymphoid irradiation 90
Liver metastases from colorectal cancer: propensity score-based comparison of stereotactic body radiation therapy vs. microwave ablation 90
Temozolomide combined with radiotherapy in the treatment of recurrent cranial meningioma previously treated with multiple surgical resections and two sessions of radiosurgery: a case report and literature review. 90
SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience. 90
Impact of the Extremities Positioning on the Set-Up Reproducibility for the Total Marrow Irradiation Treatment 89
Adjuvant radiotherapy for malignant pleural mesothelioma: Challenges and pitfalls 89
Could single-high-dose radiotherapy be considered the new frontier of stereotactic ablative radiation therapy? 89
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation 89
Oligometastatic Prostate Cancer Treated with Stereotactic Body Radiation Therapy: The Role of Three-Dimensional Tumour Volume in Patient Survival 88
Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis. 88
Can thoracic nodes oligometastases be safely treated with image guided hypofractionated radiation therapy? 88
VOLUMETRIC MODULATION ARC RADIOTHERAPY COMPARED WITH STATIC GANTRY INTENSITY-MODULATED RADIOTHERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA TUMOR: A FEASIBILITY STUDY 88
Is surgical resection useful in elderly newly diagnosed glioblastoma patients? Outcome evaluation and prognostic factors assessment 88
Liver Metastases-directed Therapy in the Management of Oligometastatic Breast Cancer 88
Assessing the role of Stereotactic Body Radiation Therapy in a large cohort of patients with lymph node oligometastases: Does it affect systemic treatment's intensification? 88
Organs at risk in lung SBRT 87
Hypofractionation in current clinical practice: a flash forward to the near future of radiation oncology? 87
CRITICAL APPRAISAL OF VOLUMETRIC MODULATED ARC THERAPY IN STEREOTACTIC BODY RADIATION THERAPY FOR METASTASES TO ABDOMINAL LYMPH NODES 87
Applying Lean-Six-Sigma Methodology in radiotherapy: Lessons learned by the breast daily repositioning case 87
Technical Note: Flattening filter free beam from Halcyon linac: Evaluation of the profile parameters for quality assurance 87
The 70-year-old newly diagnosed glioblastoma patients are older than the 65-year-old? Outcome evaluation of the two categories in a matched case control study with propensity score balancing 87
Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial 86
Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience 86
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study. 86
Low dose total marrow/total lymphoid irradiation (TMI/TLI) instead of TBI induce full donor chimerism before T-replete haploidentical transplantation (TR-H). 86
Metastatic salivary gland carcinoma: A role for stereotactic body radiation therapy? A study of AIRO‐Head and Neck working group 85
Intracranial Meningiomas: A Systematic Analysis of Prognostic Factors for Recurrence in a Large Single Institution Surgical Series 85
Bronchoscopically-guided conformal radiation therapy for radiographically occult lung carcinoma 85
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments. 85
Stereotactic Body Radiation Therapy (SBRT) for adrenal metastases A Feasibility Study of Advanced Techniques with Modulated Photons and Protons 85
Outcome Evaluation of Oligometastatic Patients Treated with Surgical Resection Followed by Hypofractionated Stereotactic Radiosurgery (HSRS) on the Tumor Bed, for Single, Large Brain Metastases. 85
Is IDH status the only factor predicting prognosis in newly diagnosed anaplastic glioma patients? Outcome evaluation and prognostic factor analysis in a single-institution large series 85
Repeated HyperArc radiosurgery for recurrent intracranial metastases and dosimetric analysis of recurrence pattern to account for diffuse dose effect on microscopical disease 84
Discrepancies between UICC and AJCC TNM classifications for oral cavity tumors in the 8th editions and following versions 84
Totale 11.524
Categoria #
all - tutte 260.169
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 260.169


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.099 0 21 31 545 13 10 87 367 195 236 513 81
2022/20236.230 950 184 550 711 552 514 9 520 1.176 533 461 70
2023/20243.204 206 383 736 116 94 318 131 140 134 60 357 529
2024/20255.284 107 154 91 67 78 576 337 583 786 1.304 573 628
2025/202615.830 2.082 965 1.810 1.704 420 592 3.927 1.115 849 884 536 946
2026/20272.454 1.139 1.315 0 0 0 0 0 0 0 0 0 0
Totale 39.953